Molecular characterization of hemophilia B in North Indian families: Identification of novel and recurrent molecular events in the factor IX gene

Haematologica

Volumn 89, Issue 12, 2004, Pages 1498-1503

  Mahajan, Anubha ^a   Chavali, Sreenivas ^a   Kabra, Madhulika ^b   Chowdhury, Madhumita Roy ^b   Bharadwaj, Dwaipayan ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Factor IX; Hemophilia B; Molecular events; North Indian

Indexed keywords

BLOOD CLOTTING FACTOR 9;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BLEEDING; FACTOR IX GENE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HEMOPHILIA B; HUMAN; INDIAN; MOLECULAR BIOLOGY; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECESSIVE INHERITANCE; X CHROMOSOME LINKED DISORDER;

AMINO ACID SUBSTITUTION; BASE PAIR MISMATCH; CHROMOSOMES, HUMAN, X; DNA MUTATIONAL ANALYSIS; EXONS; FACTOR IX; FEMALE; FRAMESHIFT MUTATION; GENETIC HETEROGENEITY; HEMOPHILIA B; HETEROZYGOTE DETECTION; HUMANS; INDIA; MALE; MUTATION, MISSENSE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; RNA SPLICE SITES; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 10444249529     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. HaemophiliaB Mutation database: (Version 12, 2003): http://www.kcl.ac.uk/ ip/petergreen/haemBdatabase.html
2. Mukherjee S, Mukhopadhyay A, Banerjee D, Chandak GR, Ray K. Molecular pathology of haemophilia B: identification of five novel mutations including a LINE 1 insertion in Indian patients. Haemophilia 2004;10:259-63.
3. Espinos C, Casana P, Haya S, Cid AR, Aznar JA. Molecular analyses in hemophilia B families: identification of six new mutations in the factor IX gene. Haematologica 2003;88:235-6.
4. Onay UV, Kavakli K, Kilinc Y, Gurgey A, Aktuglu G, Kemahli S, et al. Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations. Br J Haematol 2003;120:656-9.
5. Bowen DJ. Haemophilia A and haemophilia B; molecular insights. Mol Pathol 2002;55:127-44.
6. Bentley AK, Rees DJ, Rizza C, Brownlee GG. Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4. Cell 1986;45:343-8.
7. Jorgensen MJ, Cantor AB, Furie BC, Brown CL, Shoemaker CB, Furie B. Recognition site directing vitamin K-dependent γ-carboxylation resides on the propeptide of factor IX. Cell 1987;48:185-91.
8. Cheung WF, Hamaguchi N, Smith KJ, Stafford DW. The binding of human factor IX to endothelial cells is mediated by residues 3-11. J Biol Chem 1992;267:20529-31.
9. rd edition. New York: Cold Spring Harbor Laboratory Press. 2001.
10. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (anti-hemophilic factor B). Biochemistry 1985;24:3736-50.
11. + binding site, proteolysis in the autolysis loop, phospholipid, and factor X. J Biol Chem 1997;272:23418-26.
12. Delhi. Haemophilia 2004;10:550-2.
13. Nishimura H, Takeya H, Miyata T, Suehiro K, Okamura T, Niho Y, et al. Factor IX Fukuoka. Substitution of Asn92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X. J Biol Chem 1993;268:24041-6.
14. Chang YJ, Wu HL, Hamaguchi N, Hsu YC, Lin SW. Identification of functionally important residues of epidermal growth factor-2 domain of factor IX by alanine-scanning mutagenesis. Residues Asn (89)-Gly (93) are critical for binding factor VIIIa. J Biol Chem 2002;277:25393-9.
15. Winship PR, Dragon AC. Identification of haemophilia B with mutations in two calcium binding domains of factor IX: importance of a -OH Asp64 Asn change. Br J Haematol 1991;77:102-9.
16. Thompson AR. Molecular biology of hemophilias. In: Coller BS, eds. Progress in hemostasis and thrombosis. Pennsylvania: WB Saunders Company. 1990.
17. Ketterling RP, Drost JB, Scaringe WA, Liao DZ, Liu JZ, Kasper CK, et al. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations. Hum Mutat 1999;13:221-31.
18. McGraw RA, Davis LM, Noyes CM, Lundblad RL, Roberts HR, Graham JB, et al. Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. Proc Natl Acad Sci USA 1985;82:2847-51.
19. Smith KJ, Thompson AR, McMullen BA, Frazier D, Lin SW, Stafford D, et al. Carrier testing in hemophilia B with an immunoassay which distinguishes a prevalent factor IX dimorphism. Blood 1987;70:1006-13.
20. Bottema CD, Ketterling RP, Ii S, Yoon HS, Phillips JA, Sommer SS. Missense mutations and evolutionary conservation of aminoacids: evidence that many of the aminoacids in factor IX function as "spacer" elements. Am J Hum Genet 1991;49:820-38.